Drug-induced pancreatitis

被引：110

作者：

Claudia Nitsche

Sandrina Maertin

Jonas Scheiber

Christoph A. Ritter

Markus M. Lerch

Julia Mayerle

机构：

[1] Department of Medicine A, University Medicine, Ernst-Moritz-Arndt-University, 17475 Greifswald

[2] Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald

来源：

Current Gastroenterology Reports | 2012年 / 14卷 / 2期

关键词：

Acute pancreatitis; Adverse drug reaction; Aetiology; Drug induced pancreatitis; Medication;

D O I：

10.1007/s11894-012-0245-9

中图分类号：

学科分类号：

摘要：

Drugs are thought to be a rare cause for acute pancreatitis; however 525 different drugs are listed in the World Health Organization (WHO) database suspected to cause acute pancreatitis as a side effect. Many of them are widely used to treat highly prevalent diseases. The true incidence is not entirely clear since only few systematic population based studies exist. The majority of the available data are derived from case reports or case control studies. Furthermore, the causality for many of these drugs remains elusive and for only 31 of these 525 dugs a definite causality was established. Definite proof for causality is defined by the WHO classification if symptoms reoccur upon rechallenge. In the actual algorithm the diagnosis is confirmed if no other cause of acute pancreatitis can be detected, and the patient is taking one of the suspected drugs. © Springer Science+Business Media, LLC 2012.

引用

页码：131 / 138

页数：7

共 44 条

[1]

Lancashire R.J., Cheng K., Langman M.J.S., Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis, Alimentary Pharmacology and Therapeutics, 17, 7, pp. 887-893, (2003)

[2]

Andersen V., Sonne J., Andersen M., Spontaneous reports on druginduced pancreatitis in Denmark from 1968 to 1999, Eur J Clin Pharmacol, 57, pp. 517-521, (2001)

[3]

Balani A.R., Grendell J.H., Drug-induced pancreatitis: Incidence, managment and prevention, Drug Saf, 31, pp. 823-837, (2008)

[4]

Lankisch P.G., Droge M., Gottesleben F., Drug induced acute pancreatitis: Incidence and severity, Gut, 37, pp. 565-567, (1995)

[5]

Vinklerova I., Prochazka M., Prochazka V., Urbanek K., Incidence, severity, and etiology of drug-induced acute pancreatitis, Dig Dis Sci, 55, pp. 2977-2981, (2010)

[6]

Nitsche C.J., Jamieson N., Lerch M.M., Mayerle J.V., Drug induced pancreatitis. Best practice & research, Clin Gastroenterol, 24, pp. 143-155, (2010)

[7]

Karch F.E., Lasagna L., Adverse drug reactions, A Critical Review. JAMA, 234, pp. 1236-1241, (1975)

[8]

Eland I.A., Van Puijenbroek E.P., Sturkenboom M.J.C.M., Wilson J.H.P., Stricker B.H.Ch., Drug-associated acute pancreatitis: Twenty-one years of spontaneous reporting in the Netherlands, American Journal of Gastroenterology, 94, 9, pp. 2417-2422, (1999)

[9]

Trivedi C.D., Pitchumoni C.S., Drug-induced pancreatitis: An update, Journal of Clinical Gastroenterology, 39, 8, pp. 709-716, (2005)

[10]

Bracamonte J.D., Underhill M., Sarmiento P., Acute pancreatitis associated with lisinopril and olanzapine. Am J Health Syst Pharm: AJHP, Official J Am Soc Health Syst Pharm, 67, pp. 214-216, (2010)

← 1 2 3 4 5 →